Cited by 1,509Chemotherapy-induced cardiotoxicity and mitigationBioactive Compounds and Antitumor AgentsCancer therapeutics and mechanisms

The DOI matches its Crossref record.

Doxorubicin: The Good, the Bad and the Ugly Effect

Carvalho, Cristina, Santos, Renato, Cardoso, Susana, Correia, Sonia, Oliveira, Paulo, Santos, Maria, Moreira, Paula·2009·Current Medicinal Chemistry

DOI 10.2174/092986709788803312

Open this paper in CoChat — free account

Abstract

The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers. Despite extensive clinical utilization, the mechanisms of action of DOX remain under intense debate. A growing body of evidence supports the view that this drug can be a double-edge sword. Indeed, injury to nontargeted tissues often complicates cancer treatment by limiting therapeutic dosages of DOX and diminishing the quality of patients' life during and after DOX treatment. The literature shows that the heart is a preferential target of DOX toxicity. However, this anticancer drug also affects other organs like the brain, kidney and liver. This review is mainly devoted to discuss the mechanisms underlying not only DOX beneficial effects but also its toxic outcomes. Additionally, clinical studies focusing the therapeutic efficacy and side effects of DOX treatment will be discussed. Finally, some potential strategies to attenuate DOX-induced toxicity will be debated.

Integrity signals

Registry

Crossref · 10.2174/092986709788803312

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 301–400 of 1,000

A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues
Lucas, A. T., O’Neal, S., Santos, C., et al. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.11.035 · Cited by 43
“However, the clinical use of doxorubicin, similarly with all anthracyclines, is limited by cumulative dosedependent cardiomyopathy, which can eventually lead to heart failure, presentation ranging from 5–48% depending on dose [2,3], and carries a mortality rate of 20–40% [4].”
Background
Metabolomics facilitates the discrimination of the specific anti-cancer effects of free- and polymer-conjugated doxorubicin in breast cancer models
Armiñán, A., Palomino‐Schätzlein, M., Deladriere, C., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.015 · Cited by 43
Molecular dynamics assessment of doxorubicin–carbon nanotubes molecular interactions for the design of drug delivery systems
Contreras, M. L., Torres, C., Villarroel, I., et al. (2018) · Structural Chemistry · doi:10.1007/s11224-018-1210-5 · Cited by 44
LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells
Xiong, M., Wu, M., Peng, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03318-8 · Cited by 43
Antiphage small molecules produced by bacteria – beyond protein-mediated defenses
Hardy, A., Kever, L., & Frunzke, J. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.08.001 · Cited by 43
Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling
Yu, Y., Wu, T., Lu, Y., Zhao, W., Zhang, J., Chen, Q., Ge, G., Hua, Y., Chen, K., Ullah, I., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.10.268 · Cited by 42
Historical Perspective and Current Trends in Anticancer Drug Development
Gach, K., Drogosz-Stachowicz, J., Janecka, A. E., Wtorek, K., & Mirowski, M. (2024) · Cancers · doi:10.3390/cancers16101878 · Cited by 47
“Microtubules, made of smaller subunits, tubulin molecules, are necessary for maintaining proper cellular structure, transport, and many other cellular processes.”
Background
A new peptide ligand for colon cancer targeted delivery of micelles
Ren, Y., Mu, Y., Song, Y., Xie, J., Yu, H., Gao, S., Li, S., Peng, H., Zhou, Y., & Lu, W. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1077293 · Cited by 34
“…a widely chemotherapeutic agent used in the treatment of malignant tumors, but DOX has demonstrated severe side effects, such as dose-related acute cardiotoxicity, bone marrow suppression and multidrug resistance in the clinical use (Steinherz et al., 1991; Ray et al., 2000; Carvalho et al., 2009).”
Background
Traceable Nanoparticles with Spatiotemporally Controlled Release Ability for Synergistic Glioblastoma Multiforme Treatment
Lü, Z., Li, Y., Shi, Y., Li, Y., Xiao, Z., & Zhang, X. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703967 · Cited by 43
B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway
Wang, R., Sun, L., Xia, S., Wu, H., Ma, Y., Zhan, S., Zhang, G., Zhang, X., Shi, T., & Chen, W. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03736-2 · Cited by 41
The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy
Marques‐Aleixo, I., Alves, E. S., Oliveira, P. J., Moreira, P. I., Magalhães, J., & Ascensão, A. A. M. R. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.01.002 · Cited by 44
Self-citation
Forskolin improves sensitivity to doxorubicin of triple negative breast cancer cells via Protein Kinase A-mediated ERK1/2 inhibition
Illiano, M., Sapio, L., Salzillo, A., Capasso, L., Caiafa, I., Chiosi, E., Spina, A., & Naviglio, S. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.023 · Cited by 43
Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
Yang, Y., Feng, K., Yuan, L., Liu, Y., Zhang, M., Guo, K., Yin, Z., Wang, W., Zhou, S., Sun, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.012 · Cited by 42
Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells
Dashti, N., Akbari, V., Varshosaz, J., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131971 · Cited by 41
Preparation and Characterization of Folate Conjugated Nanoparticles of Doxorubicin using Plga-Peg-Fol Polymer
Boddu, S. H. S., & Vaishya, R. D. (2012) · Medicinal Chemistry · doi:10.4172/2161-0444.1000117 · Cited by 41
“Doxorubicin (DOX), a chemotherapeutic agent widely used in the treatment of non-Hodgkin’s lymphoma, Ewing sarcoma, multiple myeloma, acute leukemias, Wilm tumor, Kaposi sarcoma, and cancers of the lung, breast, adrenal cortex, ovary, and endometrium, was utilized in the preparation of nanoparticles [20,21].”
Background
Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast Cancer
Wu, X., Shaikh, A. B., Yu, Y., Li, Y., Ni, S., Lü, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091851 · Cited by 42
“However, its wide range of clinical applications was hampered due to emergence of drug resistance and serious cardiotoxicity [117,118].”
Background
Measurement of Free Drug Concentration from Biological Tissue by Solid-Phase Microextraction: In Silico and Experimental Study
Huq, M., Tascón, M., Nazdrajić, E., Roszkowska, A., & Pawliszyn, J. B. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00983 · Cited by 41
Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo
Besse, H. C., Rijbroek, A. D. B.-V., van der Wurff‐Jacobs, K. M. G., Bos, C., MOONEN, C. T. W., & Deckers, R. (2019) · Cancers · doi:10.3390/cancers11101512 · Cited by 41
Thymoquinone-chemotherapeutic combinations: new regimen to combat cancer and cancer stem cells
El‐Far, A. H., Tantawy, M. A., Jaouni, S. K. A., & Mousa, S. A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01898-y · Cited by 41
“Chemo-modulatory effects Doxorubicin (DOX) is a widely used chemotherapeutic agent for treatment of several carcinomas, sarcomas, and hematological cancers (Carvalho et al. 2009).”
Background
Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage
Yang, G., Song, M., Hoang, D. H., Tran, Q. H., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00541-3 · Cited by 43
Developing a simple box–behnken experimental design on the removal of doxorubicin anticancer drug using Fe3O4/graphene nanoribbons adsorbent
Sadrnia, A., Orooji, Y., Behmaneshfar, A., Darabi, R., Kamali, D. M., Karimi‐Maleh, H., Opoku, F., & Govender, P. P. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111522 · Cited by 41
Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer
Mateu‐Sanz, M., Ginebra, M., Tornín, J., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.07.007 · Cited by 41
Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery
Lin, W., Xie, X., Deng, J., et al. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1058802 · Cited by 41
“However, the heart toxicity of free DOX is serious, and this side effect has limited its clinical usage [11].”
Background
2D Nanomaterials and Their Drug Conjugates for Phototherapy and Magnetic Hyperthermia Therapy of Cancer and Infections
Silva, F. A. L. S., Chang, H., Incorvia, J. A. C., Oliveira, M. J., Sarmento, B. F. C. C., Santos, S. G., Magalhães, F. D., & Pinto, A. M. (2023) · Small · doi:10.1002/smll.202306137 · Cited by 41
Review of Carrier-Free Self-Assembly of Anticancer Nanodrugs
Ji, H., Wang, W., Qiao, O., & Hao, X. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c03315 · Cited by 45
Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F1 mice
Jenkins, G. R., Lee, T., Moland, C. L., Vijay, V., Herman, E. H., Lewis, S. M., Davis, K. J., Muskhelishvili, L., Kerr, S., Fuscoe, J. C., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.09.012 · Cited by 41
Targeting nano drug delivery to cancer cells using tunable, multi‐layer, silver‐decorated gold nanorods
Nima, Z. A., Alwbari, A. M., Dantuluri, V., et al. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3495 · Cited by 40
“Anthracyclines have a broad spectrum of activity and are currently used to treat various neoplastic conditions, including breast and prostate cancer (Arcamone et al., 1969; Carvalho et al., 2009; Swain, Whaley, & Ewer, 2003).”
Background
Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway
Hajra, S., Patra, A. R., Basu, A., Saha, P., & Bhattacharya, S. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.05.005 · Cited by 41
Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment
Pontes, O., Costa, M. F., Santos, F., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.058 · Cited by 40
Doxorubicin-loaded biodegradable capsules: Temperature induced shrinking and study of cytotoxicity in vitro
Trushina, D. B., Akasov, R., Khovankina, A. V., Borodina, T. N., Букреева, Т. В., & Арнольдовна, М. Е. (2019) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2019.03.152 · Cited by 40
Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells
Ihraiz, W. G., Ahram, M. A., & Bardaweel, S. K. (2020) · Acta Pharmaceutica · doi:10.2478/acph-2020-0020 · Cited by 40
Nanobubbles: A Novel Targeted Drug Delivery System
Pasupathy, R., Pandian, P., & Selvamuthukumar, S. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e19604 · Cited by 42
3D tumor spheroids: morphological alterations a yardstick to anti-cancer drug response
Senrung, A., Lalwani, S., Janjua, D., Tripathi, T., Kaur, J., Ghuratia, N., Aggarwal, N., Chhokar, A., Yadav, J., Chaudhary, A., et al. (2023) · In vitro models · doi:10.1007/s44164-023-00059-8 · Cited by 48
“Doxorubicin (DOX): DOX is a chemotherapeutic agent having widespread clinical application [193, 194].”
Background
Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model
Zhou, Z.-Y., Wan, L.-L., Yang, Q., Han, Y., Li, D., Lu, J., & Guo, C. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.07.710 · Cited by 39
Metal organic frameworks modified mesoporous silica nanoparticles (MSN): A nano-composite system to inhibit uncontrolled chemotherapeutic drug delivery from Bare-MSN
Adhikari, C., Mishra, A., Nayak, D., & Chakraborty, A. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.06.015 · Cited by 40
Cytotoxic and Antiproliferative Activity of Polyisoprenoids in Seventeen Mangroves Species Against WiDr Colon Cancer Cells
Sari, D. P., Basyuni, M., Hasibuan, P. A. Z., Sumardi, S., Nuryawan, A., & WATI, R. (2018) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2018.19.12.3393 · Cited by 44
Recent advances in metallodrug-like molecules targeting non-coding RNAs in cancer chemotherapy
Arjmand, F., Afsan, Z., Sharma, S., Parveen, S., Yousuf, I., Sartaj, S., Siddique, H. R., & Tabassum, S. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.02.015 · Cited by 39
Sclareol is a potent enhancer of doxorubicin: Evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer
Borges, G. S. M., Silva, J. D. O., Fernandes, R. S., de Souza, A. M., Cassali, G. D., Yoshida, M. I., Leite, E. A., de Barros, A. L. B., & Ferreira, L. A. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116678 · Cited by 39
Ultrasound-responsive alkaline nanorobots for the treatment of lactic acidosis-mediated doxorubicin resistance
Meng, X., Xu, Y., Lu, Q., Sun, L., An, X., Zhang, J., Chen, J., Gao, Y., Zhang, Y., & Ning, X. (2020) · Nanoscale · doi:10.1039/d0nr03726e · Cited by 41
Ceratonia siliqua pods (Carob) methanol extract alleviates doxorubicin-induced nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic pathways in rats
Atta, A. H., Atta, S. A., Khattab, M. S., El-Aziz, T. H. A., Mouneir, S. M., Ibrahim, M. A., Nasr, S. M., & Emam, S. R. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-28146-z · Cited by 41
Recent achievements in sodium alginate-based nanoparticles for targeted drug delivery
Rostami, E. (2021) · Polymer Bulletin · doi:10.1007/s00289-021-03781-z · Cited by 38
Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway
Lu, G., Liu, Q., Gao, T., Li, J., Zhang, J., Chen, O., Cao, C., Mao, M., Xiao, M., Zhang, X., et al. (2022) · Nutrients · doi:10.3390/nu14194017 · Cited by 40
“Although, it has been suggested that the heart is the premier target of DOX toxicity [5].”
Background
Combinatorial effects of geopropolis produced by Melipona fasciculata Smith with anticancer drugs against human laryngeal epidermoid carcinoma (HEp-2) cells
Bartolomeu, A. R., Frión-Herrera, Y., da Silva, L. M., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.03.049 · Cited by 38
A potential role for protein palmitoylation and zDHHC16 in DNA damage response
Cao, N., Li, J.-K., Rao, Y., Liu, H., Wu, J., Li, B., Zhao, P., Li, J., & Li, J. (2016) · BMC Molecular Biology · doi:10.1186/s12867-016-0065-9 · Cited by 39
“We then treated MEFs with Dox, a chemotherapeutic drug that generates double-stranded and single-stranded DNA breaks [29], and analyzed the mRNA levels of the zDHHC genes.”
Method
Folic acid-conjugated Cationic Ag 2 S Quantum Dots for Optical Imaging and Selective Doxorubicin Delivery to HeLa Cells
Duman, F. D., Erkısa, M., Khodadust, R., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0180 · Cited by 38
Synergized Multimodal Therapy for Safe and Effective Reversal of Cancer Multidrug Resistance Based on Low‐Level Photothermal and Photodynamic Effects
Xu, L., Liu, J., Xi, J., Li, Q., Chang, B., Duan, X., Wang, G., Wang, S., Wang, Z., & Wang, L. (2018) · Small · doi:10.1002/smll.201800785 · Cited by 38
One-pot synthesis of Ln 3+ -doped porous BiF 3 @PAA nanospheres for temperature sensing and pH-responsive drug delivery guided by CT imaging
Zhao, S., Tian, R., Shao, B., Feng, Y., Yuan, S., Dong, L., Zhang, L., Wang, Z., & You, H. (2019) · Nanoscale · doi:10.1039/c9nr09401f · Cited by 38
NIR-/pH-Responsive Nanocarriers Based on Mesoporous Hollow Polydopamine for Codelivery of Hydrophilic/Hydrophobic Drugs and Photothermal Synergetic Therapy
Li, S., Gan, Y., Lin, C., Lin, K., Hu, P., Liu, L., Yu, S., Zhao, S., & Shi, J. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01451 · Cited by 38
Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies
Butowska, K., Woziwodzka, A., Borowik, A., & Piosik, J. (2021) · Materials · doi:10.3390/ma14092135 · Cited by 37
Mitochondrial binding of α-enolase stabilizes mitochondrial membrane: Its role in doxorubicin-induced cardiomyocyte apoptosis
Gao, S., Li, H., Cai, Y., et al. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.008 · Cited by 38
A comparative study between conventional chemotherapy and photothermal activated nano-sized targeted drug delivery to solid tumor
Kiani Shahvandi, M., Souri, M., Tavasoli, S., Moradi Kashkooli, F., Kar, S., & Soltani, M. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107574 · Cited by 37
Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
Lee, K., Lee, M., Kwon, Y., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082997 · Cited by 37
Modelling of combination therapy using implantable anticancer drug delivery with thermal ablation in solid tumor
Al-Zu'bi, M. M., & Mohan, A. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-76123-0 · Cited by 37
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
Oo, K. K., Kamolhan, T., Soni, A., Thongchot, S., Mitrpant, C., O-Charoenrat, P., Thuwajit, C., & Thuwajit, P. (2020) · BMC Cancer · doi:10.1186/s12885-020-07761-w · Cited by 39
Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells
Azizi, E., Fouladdel, S., Movahhed, T. K., Modaresi, F., Barzegar, E., Ghahremani, M. H., Ostad, S. N., & Atashpour, S. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.12.4145 · Cited by 40
“Dox can cause DNA damage, growth arrest and cell death through DNA intercalation, topoisomerase II inhibition and free radical formation (Carvalho et al., 2009).”
Background
Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway
Huang, P., Kuo, W., Shen, C.-Y., Chen, Y.-F., Lin, Y.-M., Ho, T., Padma, V. V., Lo, J., Huang, K. C., & Huang, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091588 · Cited by 37
Solid-state emitting twisted π-conjugate as AIE-active DSE-gen: in vitro anticancer properties against FaDu and 4T1 with biocompatibility and bioimaging
Bhuin, S., Sharma, P., Chakraborty, P., Kulkarni, O. P., & Chakravarty, M. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb02078e · Cited by 36
Chemical Reactions in Living Systems
Schauenburg, D., & Weil, T. (2023) · Advanced Science · doi:10.1002/advs.202303396 · Cited by 40
Mitochondrionopathy Phenotype in Doxorubicin-Treated Wistar Rats Depends on Treatment Protocol and Is Cardiac-Specific
Pereira, G. C., Pereira, S. P., Pereira, C. V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038867 · Cited by 36
“It is intriguing that sub-chronically-treated animals showed only increase in plasma lipids, while other parameters and markers were consistently decreased even those which are usually increased in chronic exposure to DOX [16,28,29] (Table 2).”
BackgroundSelf-citation
Biocompatible stimuli‐responsive nanogels for controlled antitumor drug delivery
Aguirre, G., Villar‐Álvarez, E., González, A., et al. (2016) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.28025 · Cited by 36
Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR- γ in Mice
Yan, J., Xu, S., Kong, C., Zhou, X., Bian, Z., Yan, L., & Tang, Q. (2019) · PPAR Research · doi:10.1155/2019/2601408 · Cited by 36
Doxorubicin conjugated hydrophilic AuPt bimetallic nanoparticles fabricated from Phragmites australis: Characterization and cytotoxic activity against human cancer cells
Oladipo, A. O., Iku, S. I. I., Ntwasa, M. M., et al. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101749 · Cited by 36
The Prophylactic Effect of Pinocembrin Against Doxorubicin-Induced Cardiotoxicity in an In Vitro H9c2 Cell Model
Sangweni, N. F., Moremane, M. M., Riedel, S., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01172 · Cited by 36
Co-administration of Luteolin mitigated toxicity in rats' lungs associated with doxorubicin treatment
Owumi, S. E., Nwozo, S. O., Arunsi, U. O., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115380 · Cited by 36
Circ-SKA3 Enhances Doxorubicin Toxicity in AC16 Cells Through miR-1303/TLR4 Axis
Li, B., Cai, X., Wang, Y., Zhu, H.-M., Ping, Z., Jiang, P., Xu, Y., Sun, J., Hong, L., & Shao, L. (2021) · International Heart Journal · doi:10.1536/ihj.20-809 · Cited by 37
Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer
Behl, A., Solanki, S. S., Paswan, S. K., Datta, T. K., Saini, A. K., Saini, R. V., Parmar, V. S., Thakur, V. K., Malhotra, S., & Chhillar, A. K. (2022) · Journal of Polymers and the Environment · doi:10.1007/s10924-022-02654-4 · Cited by 40
“Nanocarriers-based smart drug delivery systems provide deeper tissue penetration and specific drug targeting, ultimately improving the safety and effectiveness of anti-cancer drugs [18, 19].”
Background
Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma
Marrero, L., Wyczechowska, D. D., Musto, A. E., Wilk, A. M., Vashistha, H., Zapata, A., Walker, C. P., Velasco‐Gonzalez, C., Parsons, C. H., Wieland, S., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.015 · Cited by 36
Caspase Mediated Synergistic Effect ofBoswellia serrataExtract in Combination with Doxorubicin against Human Hepatocellular Carcinoma
Khan, M. A., Singh, M., Khan, M. S., et al. (2014) · BioMed Research International · doi:10.1155/2014/294143 · Cited by 36
“The most important cause of DOX toxicity is oxidative stress [41].”
Background
Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trial
Xu, B.-S., Pan, Q., Hua, P., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102240 · Cited by 35
Electrospun Nanofibers: Shaping the Future of Controlled and Responsive Drug Delivery
Wildy, M., & Lü, P. (2023) · Materials · doi:10.3390/ma16227062 · Cited by 35
“This is due to injury of healthy tissues and vital organs, such as the heart, liver, kidney, and brain [112].”
Background
Effects of doxorubicin on sperm DNA methylation in mouse models of testicular toxicity
Sakai, K., Ideta-Otsuka, M., Saito, H., Hiradate, Y., Hara, K., Igarashi, K., & Tanemura, K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.044 · Cited by 35
The stimuli-responsive properties of doxorubicin adsorbed onto bimetallic Au@Pd nanodendrites and its potential application as drug delivery platform
Oladipo, A. O., Nkambule, T. T. I., Mamba, B. B., et al. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.110696 · Cited by 35
RETRACTED: Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
Ye, J., Wang, Y., Xu, Y. Q., Wang, Z., Liu, L., Wang, M., Ye, D., Zhang, J., Yang, Z., Lin, Y., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101636 · Cited by 35
Retracted
Overview on the Side Effects of Doxorubicin
Ajaykumar, C. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94896 · Cited by 37
Regulatory mechanisms of Sesn2 and its role in multi-organ diseases
Wang, J., Wang, S., Xiao, M., Zhang, J., Wang, J., Guo, Y., Tang, Y., & Gu, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105331 · Cited by 36
Heart/liver-on-a-chip as a model for the evaluation of cardiotoxicity induced by chemotherapies
Soltantabar, P., Calubaquib, E. L., Mostafavi, E., Ghazavi, A., & Stefan, M. C. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100008 · Cited by 37
“Although DOX can effectively combat the rapid division of the cells and is known as one of the most potent chemotherapeutic drugs approved by the Food and Drug Administration (FDA) (Carvalho et al., 2009), it causes toxicity to the major organs, especially life-threatening cardiotoxicity (Tacar et al., 2013).”
Background
REMOVAL OF AMOXICILLIN THROUGH DIFFERENT METHODS, EMPHASIZING REMOVAL BY BIOPOLYMERS AND ITS DERIVATIVES. AN OVERVIEW
Aranda, F. L., & Rivas, B. L. (2022) · Journal of the Chilean Chemical Society · doi:10.4067/s0717-97072022000305643 · Cited by 37
Taurine zinc solid dispersions attenuate doxorubicin-induced hepatotoxicity and cardiotoxicity in rats
Wang, Y., Mei, X., Yuan, J., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.08.017 · Cited by 35
A Simple and Sensitive HPLC Method for Fluorescence Quantitation of Doxorubicin in Micro-volume Plasma: Applications to Pharmacokinetic Studies in Rats.
Daeihamed, M., Haeri, A., & Dadashzadeh, S. (2015) · PubMed · Cited by 35
Bispecific single-chain diabody-immunoliposomes targeting endoglin (CD105) and fibroblast activation protein (FAP) simultaneously
Rabenhold, M., Steiniger, F., Fahr, A., Kontermann, R. E., & Rüger, R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.022 · Cited by 35
Anticancer Effects of Red Beet Pigments
Kapadia, G. J., & Rao, G. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3458-0_7 · Cited by 40
Unravelling Mechanisms of Doxorubicin-Induced Toxicity in 3D Human Intestinal Organoids
Rodrigues, D., Coyle, L., Füzi, B., Ferreira, S., Jo, H., Herpers, B., Chung, S., Fisher, C., Kleinjans, J. C. S., Jennen, D. G. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031286 · Cited by 35
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
Buchtová, T., Lukáč, D., Škrott, Z., Chromá, K., Bártek, J., & Mistrík, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032885 · Cited by 38
Imine-Linked Covalent Organic Frameworks: A Biocompatible and pH-Dependent Carrier for In Vitro Sustained Release of Doxorubicin
Mokhtari, N., Dinari, M., & Esmaeiltarkhani, F. K. (2023) · ACS Omega · doi:10.1021/acsomega.3c03316 · Cited by 34
Silver Nanoparticles Loaded with Oleuropein Reduce Doxorubicin-Induced Testicular Damage by Regulating Endoplasmic Reticulum Stress, and Apoptosis
Erbaş, E., Gelen, V., Kara, H., Gedikli, S., Yeşildağ, A., Özkanlar, S., & Akarsu, S. A. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04058-y · Cited by 34
Nanotechnology-based drug delivery systems for curcumin and its derivatives in the treatment of cardiovascular diseases
Sun, Q., Lv, M., & Li, Y. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106476 · Cited by 35
Injectable supramolecular hydrogels fabricated from PEGylated doxorubicin prodrug and α-cyclodextrin for pH-triggered drug delivery
Li, F., He, J., Zhang, M., Tam, K. C., & Ni, P. (2015) · RSC Advances · doi:10.1039/c5ra06156c · Cited by 34
Tert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genes.
Wang, L., Su, S., Wang, L., Zhang, G., Zhang, R., Niu, Y., Guo, Y., Li, C., Jiang, W., Liu, Y., et al. (2015) · Europe PMC (PubMed Central) · Cited by 34
Drug delivery system composed of mesoporous silica and hollow mesoporous silica nanospheres for chemotherapeutic drug delivery
Adhikari, C., Mishra, A., Nayak, D., et al. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.03.020 · Cited by 34
Doxorubicin generates senescent microglia that exhibit altered proteomes, higher levels of cytokine secretion, and a decreased ability to internalize amyloid β
Marques, L., Johnson, A. A., & Stolzing, A. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112203 · Cited by 35
Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation
Pradipta, A. R., Ahmadi, P., Terashima, K., et al. (2021) · Chemical Science · doi:10.1039/d0sc06083f · Cited by 34
Green Synthesis of Silver Nanoparticles Using Spilanthes acmella Leaf Extract and its Antioxidant-Mediated Ameliorative Activity against Doxorubicin-Induced Toxicity in Dalton’s Lymphoma Ascites (DLA)-Bearing Mice
Lalsangpuii, F., Rokhum, S. L., Nghakliana, F., et al. (2022) · ACS Omega · doi:10.1021/acsomega.2c05970 · Cited by 34
Potential of four marine-derived fungi extracts as anti-proliferative and cell death-inducing agents in seven human cancer cell lines
Ramos, A. A., Prata‐Sena, M., Castro‐Carvalho, B., Dethoup, T., Buttachon, S., Kijjoa, A., & Rocha, E. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2015.09.005 · Cited by 33
“However, most of the anticancer drugs currently used, such as doxorubicin, give rise to undesirable side effects, such as cardiotoxicity and tumor drug-resistance [5] .”
Lactobacillus caseiHY7213 ameliorates cyclophosphamide-induced immunosuppression in mice by activating NK, cytotoxic t cells and macrophages
Jang, S., Joh, E., Ahn, Y., et al. (2013) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2013.789055 · Cited by 34
Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs
Martinez, J. O., Evangelopoulos, M., Bhavane, R. C., et al. (2015) · Current Drug Targets · doi:10.2174/1389450115666141015113914 · Cited by 34
“Doxorubicin (DOX) [7] and melittin (MEL) [8-11], which is the primary component of bee venom, are well-established therapeutics for cancer.”
Background
Zeolitic Imidazolate Framework (ZIF-8) Decorated Iron Oxide Nanoparticles Loaded Doxorubicin Hydrochloride for Osteosarcoma Treatment - in vitro and in vivo Preclinical Studies
Wu, W., Yu, X., Sun, J., Han, Y., Ma, Y., Zhang, G., Ma, Q., Li, Q., & Xiang, H. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s438771 · Cited by 33
Protective effect of ocotillol against doxorubicin-induced acute and chronic cardiac injury
Fu, X., KONG, L., Tang, M., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1791 · Cited by 33
CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
Gao, J., Zheng, Q., Shao, Y., Wang, W., & Zhao, C. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1473-8 · Cited by 33
Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
Lebrón, J. A., López‐López, M., García-Calderón, C. B., Rosado, I. V., Balestra, F. R., Huertas, P., Rodik, R. V., Kаlchеnkо, V. I., Bernal, E., Moyá, M. L., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081250 · Cited by 32
Co-delivery of NIR-II semiconducting polymer and pH-sensitive doxorubicin-conjugated prodrug for photothermal/chemotherapy
Yu, D., Wang, Y., Chen, J., Liu, S., Deng, S., Liu, C., McCulloch, I. A., Yue, W., & Cheng, D. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.10.009 · Cited by 33

Authors: Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P.
Affiliations: Centro de Neurociências e Biologia Celular (PT)
Corresponding author: Moreira, Paula
ORCID: Carvalho, Cristina
Santos, Renato
Cardoso, Susana
Oliveira, Paulo
Santos, Maria
Moreira, Paula
Venue: Current Medicinal Chemistry
Publisher: Bentham Science Publishers Ltd.
Published: 2009-09-01
Volume: 16
Issue: 25
Pages: 3267-3285
ISSN: 0929-8673 (ISSN-L)
DOI: 10.2174/092986709788803312
OpenAlex: W2102897174
Cited by: 1,509
References: 0
Citations by year: 2026: 102 · 2025: 147 · 2024: 174 · 2023: 169 · 2022: 153 · 2021: 150 · 2020: 120 · 2019: 85 · 2018: 84 · 2017: 53 · 2016: 63 · 2015: 62 · 2014: 43 · 2013: 35 · 2012: 29
FWCI: 14.12
Type: journal article
Language: en
Open access: closed
Locations: Current Medicinal Chemistry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords: doxorubicin, anthracyclines, cardiotoxicity, drug toxicity mechanisms, anticancer mechanism, neurotoxicity, nephrotoxicity, hepatotoxicity, chemotherapy side effects
MeSH terms: Antibiotics, Antineoplastic, Doxorubicin, Humans, Molecular Conformation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Doxorubicin: The Good, the Bad and the Ugly Effect

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks